twitterlinkedin
  • About
  • Team
  • Services
  • Research
  • Closings
  • Contact Us

WCAS XIII

Posted on July 25, 2019October 10, 2024 by lknoop

U.S. Middle-Market

Technology and

Healthcare Buyout

Bookmark the permalink.

Post navigation

← Forebright New Opportunities Fund II
Centurium Capital Partners 2018 →

Archives

Categories

  • No categories

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Probitas Funds Group, LLC ("PFG") is a member of FINRA and the U.S. Securities and Exchange Commission. PFG is also a member of SIPC. There are several members of the Probitas Partners group of companies. PFG-UK Ltd. is authorized and regulated by the Financial Conduct Authority and Probitas Hong Kong Limited is licensed to carry on Type 1 and Type 4 regulated activities in Hong Kong. Probitas Partners (Europe) AS is a licensed investment firm with the Norwegian Financial Supervisory Authority and is licensed to operate in all EU/EEA countries by means of passporting under MiFID2. In addition, PFG is licensed as an international securities dealer in the Province of Ontario and licensed as a Type 2 Financial Dealer in Japan. PFG and PFG-UK Ltd. are exempt from registration in Australia by the ASIC.

Probitas Partners, L.P. © 2024   |   Privacy Policy   |   Business Continuity Disclosure   |   FINRA BrokerCheck   |   Financial Services Web Design by Thomas Digital